FIELD: medicine.
SUBSTANCE: invention relates to medicine. Disclosed is a method of preimplantation genetic diagnosis of Fanconi anemia in an embryo, which involves detection of mutations c.731T> A (p.L244X), c.1844dupC and deletion of 1–3 exons of the FANCA gene by direct and indirect diagnosis. Direct diagnostics involves determination of point mutation c.731T> A (p.L244X) and mutation c.1844dupC by PCR-RFLP method, and indirect diagnosis for deletion of 1–3 exon of FANCA gene involves semi-nested PCR for analysis of inheritance of molecular-genetic markers linked with a mutation. If observing mutations c.731T> A (p.L244X), c.1844dupC or deletion of 1–3 exon of FANCA gene, Fanconi anemia is diagnosed in an embryo.
EFFECT: invention provides effective preimplantation genetic diagnosis of Fanconi anemia, providing for detection of mutations c.731T> A (p.L244X), c.1844dupC and deletion of 1–3 FANCA gene exon by direct and indirect diagnosis.
1 cl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PREIMPLANTATION GENETIC TESTING METHOD FOR FANCONI ANEMIA | 2022 |
|
RU2792147C1 |
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF CYSTIC FIBROSIS | 2021 |
|
RU2777078C1 |
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF TYPE 1 FAMILIAL FOCAL EPILEPSY | 2021 |
|
RU2777084C1 |
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF LOUIS-BAR SYNDROME | 2021 |
|
RU2777081C1 |
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF EPIDERMOLYSIS BULLOSA | 2021 |
|
RU2777086C1 |
CANAVAN DISEASE PREIMPLANTATION GENETIC TESTING METHOD | 2020 |
|
RU2748289C1 |
METHOD FOR PREIMPLANTATION GENETIC TESTING OF NON-SYNDROMIC SENSORINEURAL HEARING LOSS | 2022 |
|
RU2791878C1 |
TEST SYSTEM FOR PRENATAL GENETIC TESTING FOR HLA-COMPATIBILITY | 2020 |
|
RU2728215C1 |
METHOD FOR PRE-IMPLANTATION GENETIC TESTING OF FAMILIAL HYPERTROPHIC CARDIOMYOPATHY | 2021 |
|
RU2772938C1 |
METHOD OF PREIMPLANTATION GENETIC TESTING FOR SPONDYLOEPIPHYSEAL DYSPLASIA | 2022 |
|
RU2803650C1 |
Authors
Dates
2019-08-14—Published
2018-01-23—Filed